CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-06-26 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2024-06-17 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-27 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-06-27 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2021-06-09 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-06-11 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | ||
| 2019-07-18 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 |
Page 1 of 1 · 8 trades